261 related articles for article (PubMed ID: 18304215)
1. Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population.
Shao J; Gu M; Zhang Z; Xu Z; Hu Q; Qian L
Int J Urol; 2008 Mar; 15(3):216-21. PubMed ID: 18304215
[TBL] [Abstract][Full Text] [Related]
2. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
Tan W; Song N; Wang GQ; Liu Q; Tang HJ; Kadlubar FF; Lin DX
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):551-6. PubMed ID: 10868687
[TBL] [Abstract][Full Text] [Related]
3. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer.
Srivastava DS; Mishra DK; Mandhani A; Mittal B; Kumar A; Mittal RD
Eur Urol; 2005 Aug; 48(2):339-44. PubMed ID: 16005379
[TBL] [Abstract][Full Text] [Related]
5. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.
Kim EJ; Jeong P; Quan C; Kim J; Bae SC; Yoon SJ; Kang JW; Lee SC; Jun Wee J; Kim WJ
Urology; 2005 Jan; 65(1):70-5. PubMed ID: 15667866
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer.
Hung HC; Chuang J; Chien YC; Chern HD; Chiang CP; Kuo YS; Hildesheim A; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):901-5. PubMed ID: 9367063
[TBL] [Abstract][Full Text] [Related]
7. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
Wu SH; Tsai SM; Hou MF; Lin HS; Hou LA; Ma H; Lin JT; Yeh FL; Tsai LY
Breast Cancer Res Treat; 2006 Nov; 100(1):93-8. PubMed ID: 16758119
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1.
Lin DX; Tang YM; Peng Q; Lu SX; Ambrosone CB; Kadlubar FF
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1013-8. PubMed ID: 9829710
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
Wu MS; Chen CJ; Lin MT; Wang HP; Shun CT; Sheu JC; Lin JT
Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer.
Gattás GJ; de Carvalho MB; Siraque MS; Curioni OA; Kohler P; Eluf-Neto J; Wünsch-Filho V
Head Neck; 2006 Sep; 28(9):819-26. PubMed ID: 16721740
[TBL] [Abstract][Full Text] [Related]
11. Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study.
Karagas MR; Park S; Warren A; Hamilton J; Nelson HH; Mott LA; Kelsey KT
Cancer Lett; 2005 Feb; 219(1):63-9. PubMed ID: 15694665
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of the XRCC7 gene involved in DNA repair and risk of human bladder cancer.
Wang SY; Peng L; Li CP; Li AP; Zhou JW; Zhang ZD; Liu QZ
Int J Urol; 2008 Jun; 15(6):534-9. PubMed ID: 18422577
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India.
Srivastava DS; Kumar A; Mittal B; Mittal RD
Arch Toxicol; 2004 Aug; 78(8):430-4. PubMed ID: 15057507
[TBL] [Abstract][Full Text] [Related]
15. Exon 3 polymorphisms and haplotypes of O6-methylguanine-DNA methyltransferase and risk of bladder cancer in southern China: a case-control analysis.
Li C; Liu J; Li A; Qian L; Wang X; Wei Q; Zhou J; Zhang Z
Cancer Lett; 2005 Sep; 227(1):49-57. PubMed ID: 15885889
[TBL] [Abstract][Full Text] [Related]
16. Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea.
Lee KM; Kang D; Lee SJ; Park SK; Lee KH; Choi JY; Kim SU; Choi H; Choi SH; Kim YW; Hong YC; Cho SH
Oncol Rep; 2006 Nov; 16(5):1035-9. PubMed ID: 17016589
[TBL] [Abstract][Full Text] [Related]
17. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
[TBL] [Abstract][Full Text] [Related]
18. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population.
Öztürk T; Kahraman ÖT; Toptaş B; Kisakesen Hİ; Çakalir C; Verim L; Öztürk O; İsbir T
In Vivo; 2011; 25(4):663-8. PubMed ID: 21709011
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India.
Sobti RC; Al-Badran AI; Sharma S; Sharma SK; Krishan A; Mohan H
Cancer Genet Cytogenet; 2005 Jan; 156(1):68-73. PubMed ID: 15588859
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
Ruwali M; Khan AJ; Shah PP; Singh AP; Pant MC; Parmar D
Environ Mol Mutagen; 2009 Jul; 50(6):473-82. PubMed ID: 19334053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
